[Systemic approach to investigation of levitra efficacy in patients with chronic prostatitis with erectile dysfunction]
| Autor: | Iu G, Aliaev, M A, Ronkin, Iu M, Esilevskiĭ, T D, Zhuchenko, Iu L, Demidko, G E, Krupinov, V Iu, Shcherbanina |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Cyclic Nucleotide Phosphodiesterases
Type 5 Male Phosphodiesterase Inhibitors Phosphoric Diester Hydrolases Triazines Imidazoles Prostate Drug Administration Schedule Piperazines Prostatitis Treatment Outcome Erectile Dysfunction Vardenafil Dihydrochloride 3' 5'-Cyclic-GMP Phosphodiesterases Regional Blood Flow Cerebrovascular Circulation Testis Humans Sulfones Penis |
| Zdroj: | Urologiia (Moscow, Russia : 1999). (2) |
| ISSN: | 1728-2985 |
| Popis: | Ultrasonic dopplerography of prostatic, scrotal and penile vessels before and after intake of levitra in a dose 10 mg was made in 22 patients with chronic abacterial prostatitis in combination with erectile dysfunction and after their combined levitra treatment for a month taken each other day. It was found that levitra accelerates arterial inflow to the prostatic gland, testicles and penis (even in the absence of sexual stimulation and erection). This evidence indicates a distinct vasculogenic effect of levitra on male genitalia. Thus, levitra is a promising drug in the treatment of chronic prostatitis, excretory infertility. It is recommended to take levitra regularly 2-3 times a week to manage vascular genital disorders. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|